TITLE:
Alternate-Day Buprenorphine. Phase V - 6

CONDITION:
Opioid-Related Disorders

INTERVENTION:
Buprenorphine

SUMMARY:

      The purpose of this study is to evaluate buprenorphine blockade challenge.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 30 Years to 49 Years
Criteria:

        Please contact site for information.
      
